Untangling the Web of Antiretroviral Price Reductions. 13th Edition, July 2010
(2010; 104 pages)

Abstract

MSF is currently supporting care and treatment for more than 154,000 people in 27 countries. By the end of 2008, a total of four million people across the developing world were on ART. Delivering ART to millions of people in developing countries was made possible because treatment was brought close to where people lived, the price of medicines came down dramatically, and treatment was simplified and made more patient-friendly, with several medicines combined into one pill (known as a fixed-dose combination, or FDC). And in order to address the shortages of medical staff in many countries, tasks are being shifted, so that nurses or nurse aides can perform many of the duties previously reserved for doctors. While these achievements represent important progress, the crisis is far from over. Until recently it was estimated that almost 10 million people are in immediate need of treatment, a testament to the persistent emergency. With the revision of the World Health Organization (WHO) guidelines in late 2009, which recommend, in line with current evidence, that treatment be initiated earlier in a patient’s disease progression, the number of patients in need of ART is expected by some to increase by a further five million to around 14 million people. The number of people who will need treatment by 2030 has been projected to reach as many as 55 million...

 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019